Pages that link to "Q59095410"
Jump to navigation
Jump to search
The following pages link to Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas (Q59095410):
Displaying 50 items.
- Acromegaly (Q21202912) (← links)
- Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation (Q24311922) (← links)
- Acromegaly pathogenesis and treatment (Q24647360) (← links)
- Pituitary adenomas: historical perspective, surgical management and future directions (Q26779749) (← links)
- MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics (Q28088746) (← links)
- Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas (Q28306491) (← links)
- Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis (Q28344662) (← links)
- Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior. (Q30445060) (← links)
- Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors (Q30445064) (← links)
- Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release (Q30449260) (← links)
- Growth hormone-secreting adenomas: pathology and cell biology (Q30451931) (← links)
- GH mRNA levels are elevated by forskolin but not GH releasing hormone in GHRH receptor-expressing MtT/S somatotroph cell line (Q31875662) (← links)
- Signaling pathway networks mined from human pituitary adenoma proteomics data (Q33567346) (← links)
- Pathogenesis of pituitary tumors (Q33596291) (← links)
- Mechanisms for pituitary tumorigenesis: the plastic pituitary (Q33630319) (← links)
- Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment (Q33849218) (← links)
- Corticosterone differentially regulates the expression of Gs alpha and Gi alpha messenger RNA and protein in rat cerebral cortex (Q33859870) (← links)
- Gs alpha mutations in hyperfunctioning thyroid adenomas (Q33861215) (← links)
- Clinical implications of genetic defects in G proteins: oncogenic mutations in G alpha s as the molecular basis for the McCune-Albright syndrome (Q33861221) (← links)
- The Drosophila gene coding for the alpha subunit of a stimulatory G protein is preferentially expressed in the nervous system (Q33868535) (← links)
- Molecular basis of pituitary oncogenesis (Q33870363) (← links)
- Abnormalities in G protein-coupled signal transduction pathways in human disease (Q33900844) (← links)
- Genetically engineered mouse models of pituitary tumors (Q33984418) (← links)
- Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes (Q34084115) (← links)
- Familial acromegaly: case report and review of the literature (Q34084133) (← links)
- The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis (Q34102786) (← links)
- Transforming G proteins (Q34226022) (← links)
- Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas. (Q34301711) (← links)
- Signal transduction through the cAMP-dependent protein kinase (Q34323975) (← links)
- Genesis of pituitary adenomas: state of the art. (Q34473702) (← links)
- G-protein-coupled receptors and cancer. (Q34606002) (← links)
- Mutations in G protein β subunits promote transformation and kinase inhibitor resistance (Q34893087) (← links)
- The pathogenesis of pituitary tumours (Q34988259) (← links)
- Molecular defects in the pathogenesis of pituitary tumours (Q35134268) (← links)
- Recurrent gain-of-function USP8 mutations in Cushing's disease (Q35146226) (← links)
- Investigation of the vitamin D receptor polymorphisms in acromegaly patients (Q35206714) (← links)
- G protein-controlled signal transduction pathways and the regulation of cell proliferation (Q35251530) (← links)
- Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway (Q35311177) (← links)
- Genetics of Pituitary Tumors: Focus on G-Protein Mutations (Q35552656) (← links)
- Regulation of growth hormone secretion by (pro)renin receptor (Q35679184) (← links)
- Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. (Q35763542) (← links)
- Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas (Q35786043) (← links)
- Pituitary pathology in acromegaly. (Q35816115) (← links)
- Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix (Q35832096) (← links)
- Pharmacology of second messengers: a critical appraisal (Q36071589) (← links)
- Stimulation of human thyroid growth via the inhibitory guanine nucleotide binding (G) protein Gi: constitutive expression of the G-protein alpha subunit Gi alpha-1 in autonomous adenoma (Q36117740) (← links)
- Inactivating and activating mutations of the Gs alpha gene (Q36179251) (← links)
- Signal transduction in endocrine tissues (Q36264191) (← links)
- Pathogenesis of prolactinomas. (Q36367489) (← links)
- Mechanisms of disease: The pathogenesis of pituitary tumors (Q36576996) (← links)